¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"AMPHETAMINE ASPARTATE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DOM Dimeth-Oxy-Methyl amphetamine
MPA   1) Mean Pulmonary Artery
  2) Medroxy-Progesterone Acetate(Provera¨Þ)
&nb...
TMA Tri-Methoxy Amphetamine
AIRS Amphetamine Interview Rating Scale
AMP accelerated mental processes; acid mucopolysaccharide; adenosine monophosphate; amphetamine; ampicil...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AMPH 1-amphetamine
MDA 3,4-(+/-)-(methylenedioxy)amphetamine
A Amphetamine
AM Amphetamine
AMP Amphetamine
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® aspartate aminotransferase(AST) ÇÑ±Û ¾Æ½ºÆÄ¶óÁø»ê ¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
¼³¸í   
  SGOT(Serum Glutamic Oxalacetic Transaminase)¶ó°íµµ Çϴ À̰ÍÀº Á¤»óÀûÀ¸·Î °£¼¼Æ÷¿Í ±ÙÀ°¼¼Æ÷ µî¿¡ ¸î°¡Áö µ¿Á¾È¿¼Ò(±â´ÉÀº °°Áö¸¸ ±¸Á¶°¡ ¾à°£¾¿ ´Ù¸¥ È¿¼ÒÇüÅÂ)ÀÇ ÇüÅ·ΠÁ¤»óÀûÀ¸·Î Á¸ÀçÇÑ´Ù. ±ÙÀ°¼¼Æ÷³ª °£¼¼Æ÷ÀÇ ÆÄ±«°¡ ¿À´Â °£º´À̳ª ±ÙÀ°º´¿¡¼­ Ç÷¾×¿¡ Àִ ÀÌ È¿¼ÒÀÇ ¾çÀÌ ÇöÀúÇϰԠÁõ°¡ÇÑ´Ù.
¿µ¹® amphetamine ÇÑ±Û ¾ÏÆäŸ¹Î
¼³¸í   
  ÇÊ·ÎÆùÀ¸·Î À¯¸íÇÑ ÀÌ ¾àÀÇ ÁÖÀÛ¿ëÀº ÁßÃ߽Űæ°è¸¦ ÀÚ±ØÇϴ °ÍÀÌ´Ù. ÁßÃ߽Űæ°èÀÇ ÀÚ±ØÀ¸·Î ÀÎÇØ¼­ ÇǷΰ¨À» ´ú ´À³¢°Ô µÇ°í Àáµµ ¿ÀÁö ¾Ê°Ô µÈ´Ù. ÇÏÁö¸¸ Áßµ¶¼ºÀÌ °­Çϰí Áö¼ÓÀûÀ¸·Î Åõ¿©ÇÒ °æ¿ì¿£ Á¤½Åº´°ú °°Àº Áõ»ó, Ç÷¾Ð»ó½Â, ¾ÈÀýºÎÀý µîÀÇ Áõ»óÀ» ³ªÅ¸³½´Ù. ±×¸®°í Áö¼ÓÀûÀ¸·Î º¹¿ëÇÏ´ø »ç¶÷ÀÌ ¾àÀ» ²÷¾úÀ» °æ¿ì¿¡´Â ½ÉÇÑ ±Ý´ÜÁõ»óÀ» °Þ°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amphetamine
    ¾ÏÆäŸ¹Î
  • aspartate aminotransferase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀü´ÞÈ¿¼Ò
  • aspartate transaminase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀü´ÞÈ¿¼Ò
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amphetamine
    ¾ÏÆäŸ¹Î
  • aspartate aminotransferase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amphetamine
    ¾ÏÆäŸ¹Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AST => aspartate aminotransferase
    ¾Æ½ºÆÄŽ¾Æ¹Ì³ëÆ®¶õ½ºÆä¶óÁ¦
  • amphetamine
    ¾ÏÆäŸ¹Î(°¢¼ºÁ¦).
  • amphetamine psychosis
    ¾ÏÆäŸ¹Î Á¤½ÅÁõ(º´)
  • aspartate
    ¾Æ½ºÆÄ¶óÁø»ê¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amphetamine
    ¾ÏÆäŸ¹Î(°¢¼ºÁ¦).
  • amphetamine psychosis
    ¾ÏÆäŸ¹Î Á¤½ÅÁõ(º´)
  • aspartate
    ¾Æ½ºÆÄ¶óÁø»ê¿°
  • mitochondrial aspartate aminotransferase
    ¾Æ½ºÆÄ¸£Å×ÀÌÆ®¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amphetamine
    ¾ÏÆäŸ¹Î
  • aspartate trascarbamoylase
    ¾Æ½ºÆÄ¸£Æ®»ê(ß«)Æ®¶õ½ºÄ«¹Ù¸ðÀÏ·¹À̽º
  • malate-aspartate shuttle
    ¸»»ê(ß«).¾Æ½ºÆÄ¸£Æ®»ê(ß«) ¼ÅƲ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • amphetamine
    ¾ÏÆäŸ¹Î
    Á¤½Å ÈïºÐÁ¦ÀÌ°í °¢¼ºÁ¦¿Í ºñ½ÁÇÏ´Ù. ±³°¨½Å°æ¼º ÀÛ¿ëÀ» Áö´Ï°í ÁßÃ߽Űæ ÈïºÐ ÀÛ¿ëÀÌ °­Çϱ⠶§¹®¿¡ ¿¡Æäµå¸°°ú ºñ½ÁÇÏ´Ù. ÁøÅë ÀÛ¿ëÀÌ ÀÖ°í ¸ôÇɰúÀÇ Çù·ÂÀÛ¿ëÀÌ ÀÖÀ¸¸ç ½Ä¿å °¨Åðµµ ÀÖ´Ù. ÀÚÀ²½Å°æ ÈïºÐÀÛ¿ëÀÌ ÀÖ´Ù.
  • aspartate
    ¾Æ½ºÆÄ¶óÁø»ê¿°
  • aspartate aminotransferase
    ¾Æ½ºÆÄ¶óÁø»ê ¾Æ¹Ì³ëÆ®¶õ½ºÆÛ·¹À̽º
    ÀüÀÌ È¿¼Ò·Î¼­, L-as
  • AST : aspartate aminotransferaseÀÇ ¾àÀÚ.

    astasia abasia

    ±â¸³ º¸Çà ºÒ´ÉÁõ
    ´Ù¸®°¡ ´Ù¸¥ Á¡¿¡¼­´Â Á¶ÀýµÇ´Âµ¥µµ ºÒ±¸Çϰí, ±â¸³ ¶Ç ´Â º¸ÇàÀÌ ¾ÈµÇ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
amphetamine <drug> Drug of abuse that acts by increasing extraneuronal dopamine in midbrain. Thought to displace dopamine in synaptic vesicles, leading to increased synaptic levels.
(18 Nov 1997)
amphetamine-related disorders Disorders related or resulting from use of amphetamines.
(12 Dec 1998)
d-amphetamine phosphate Monobasic d-alpha-methylphenethylamine phosphate;same actions and uses as dextroamphetamine sulfate.
Synonym: d-amphetamine phosphate.
(05 Mar 2000)
d-amphetamine sulfate (+)-alpha-methylphenethylamine sulfate;similar in action to racaemic amphetamine sulfate, but is more stimulating to the central nervous system; sympathomimetic and appetite depressant.
Synonym: d-amphetamine sulfate, dexamphetamine.
(05 Mar 2000)
aspartate <amino acid> A nonessential amino acid that plays a critical part of the enzyme in the liver that transfers nitrogen-containing amino groups, either in building new proteins and amino acids or in breaking down proteins and amino acids for energy and detoxifying the nitrogen in the form of urea.
Depleted levels of aspartic acid may occur temporarily within certain tissues under stress, but, because the body is able to make its own aspartic acid to replace any depletion, deficiency states do not occur.
Aspartic acid is abundant in plants, especially in sprouting seeds. In protein, it exists mainly in the form of its amide, asparagine.
The popular sweetener Aspartame is a combination of aspartic acid and phenylalanine. Aspartic acid is considered nontoxic.
(15 Nov 1997)
aspartate 1-decarboxylase <enzyme> A pyridoxal-phosphate protein that catalyses the alpha-decarboxylation of l-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining gaba levels in normal nervous tissues. The brain enzyme also acts on l-cysteate, l-cysteine sulfinate, and l-aspartate.
Chemical name: L-Glutamate-1-carboxy-lyase
Registry number: EC 4.1.1.15
(12 Dec 1998)
aspartate 4-decarboxylase Aspartate beta-decarboxylase;a carboxy-lyase converting l-aspartate to l-alanine (releasing CO2); it decarboxylates aminomalonate and (in bacteria) removes SO2 from cysteinesulfinate.
See: desulfinase.
(05 Mar 2000)
aspartate-alpha-decarboxylase <enzyme> Forms beta-alanine
Registry number: EC 4.1.1.11
Synonym: aspartate 1-decarboxylase
(26 Jun 1999)
aspartate aminotransferase <enzyme> An enzyme catalyzing the reversible transfer of an amine group from l-glutamic acid to oxaloacetic acid, forming alpha-ketoglutaric acid and l-aspartic acid; a diagnostic aid in viral hepatitis and in myocardial infarctions.
Synonym: aspartate transaminase, glutamic-aspartic transaminase, glutamic-oxaloacetic transaminase, serum glutamic-oxaloacetic transaminase.
(05 Mar 2000)
aspartate-ammonia ligase <enzyme> An enzyme that catalyses the formation of asparagine from ammonia and aspartic acid, in the presence of ATP.
Chemical name: L-Aspartate:ammonia ligase (AMP-forming)
Registry number: EC 6.3.1.1
(12 Dec 1998)
aspartate ammonia-lyase <enzyme> An enzyme that catalyses the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms.
Chemical name: L-Aspartate ammonia-lyase
Registry number: EC 4.3.1.1
(12 Dec 1998)
aspartate carbamoyltransferase <enzyme> An enzyme that catalyses the conversion of carbamoyl phosphate and l-aspartate to yield orthophosphate and n-carbamoyl-l-aspartate.
Chemical name: Carbamoyl-phosphate:L-aspartate carbamoyltransferase
Registry number: EC 2.1.3.2
(12 Dec 1998)
aspartate kinase <enzyme> An enzyme that catalyses the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine.
Chemical name: ATP:L-aspartate 4-phosphotransferase
Registry number: EC 2.7.2.4
(12 Dec 1998)
aspartate N-acetyltransferase <enzyme> Nervous system enzyme that mediates synthesis of n-acetylaspartic acid; utilises acetyl-CoA
Registry number: EC 2.3.1.17
(26 Jun 1999)
aspartate-saemialdehyde dehydrogenase <enzyme> An enzyme that catalyses the conversion of l-aspartate 4-saemialdehyde, orthophosphate, and NADP+ to yield l-4-aspartyl phosphate and NADPH.
Chemical name: L-Aspartate-4-saemialdehyde:NADP+ oxidoreductase (phosphorylating)
Registry number: EC 1.2.1.11
(12 Dec 1998)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
amphetamine aspartate the aspartate salt of amphetamine, having the same actions and uses as the sulfate salt; administered orally.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amphetamine
    ¾ÏÆäŸÀÎ(ÃæÃß ½Å°æÀ» ÀÚ±ØÇÏ´Â °¢¼ºÁ¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á